Compound Summary
Compound Information
5-BROMO-2'-DEOXYURIDINE
Compound Name: | 5-BROMO-2'-DEOXYURIDINE |
Compound CID: | 6035 |
Synonyms: | "5-BROMO-2-DEOXYURIDINE 59-14-3 Broxuridine Bromodeoxyuridine 5-Bromodeoxyuridine More... |
Iupac Name: | 5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione |
InChI: | InChI=1S/C9H11BrN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1 |
InChIKey: | WOVKYSAHUYNSMH-RRKCRQDMSA-N |
Canonical Smiles: | C1C(C(OC1N2C=C(C(=O)NC2=O)Br)CO)O |
Isomeric Smiles: | C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)Br)CO)O |
Molecular Weight: | 307.1 |
Molecular Formula: | C9H11BrN2O5 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
5-BROMO-2'-DEOXYURIDINE
Molecular Weight: | 307.1 |
Molecular Formula: | C9H11BrN2O5 |
Hydrogen Bond Donor Count: | 3 |
Hydrogen Bond Acceptor Count: | 5 |
Rotatable Bond Count: | 2 |
Heavy Atom Count: | 17 |
Complexity: | 386 |
Synonyms
5-BROMO-2'-DEOXYURIDINE
| 5-BROMO-2'-DEOXYURIDINE | 5-BROMO-2'-DEOXYURIDINE |
|---|---|
"5-BROMO-2-DEOXYURIDINE |
59-14-3 |
Broxuridine |
Bromodeoxyuridine |
5-Bromodeoxyuridine |
5-BrdU |
BRDU |
BUDR |
5-Bromouracil deoxyriboside |
Bromouracil deoxyriboside |
5-Bromodesoxyuridine |
5-Bdu |
Broxuridinum |
5-Bromo-2-deoxyuridine |
Broxuridina |
5-Bromouracil-2-deoxyriboside |
C9H11BrN2O5 |
NSC-38297 |
UNII-G34N38R2N1 |
CHEBI:472552 |
MFCD00006529 |
5-bromo-2-deoxy uridine |
CHEMBL222280 |
5-Bromo-1-(2-deoxy-beta-D-ribofuranosyl)uracil |
G34N38R2N1 |
5-Bromo-2-deoxyuridine (BRDU) |
NCGC00090770-05 |
5-bromo-2-desoxyuridine |
DSSTox_CID_13105 |
DSSTox_RID_79051 |
DSSTox_GSID_33105 |
5-bromo-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione |
Broxuridinum INN-Latin |
BDU |
Broxuridina INN-Spanish |
CAS-59-14-3 |
1-(4S,2R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl-5-bromo-1,3-dihydropyrim idine-2,4-dione |
SMR001227189 |
bromodeoxyuridine (brdu) |
CCRIS 818 |
HSDB 7477 |
Broxuridine INN:JAN |
EINECS 200-415-9 |
(+)-5-Bromo-2-deoxyuridine |
BRN 0030395 |
5-Bromo-2-deoxyuridine(BRDU) |
5-bromo-1-(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-ylpyrimidine-2,4-dione |
5-Bromo-dURD |
5-brom-2-desoxyuridin |
Broxuridine (JAN/INN) |
Maybridge4_003385 |
Epitope ID:138105 |
cid_6035 |
Lopac0_000212 |
SCHEMBL27755 |
4-24-00-01234 (Beilstein Handbook Reference) |
MLS001055406 |
MLS002153366 |
DTXSID7033105 |
5-Bromo-2-deoxyuridine, 97% |
HMS1619B05 |
HMS3039G15 |
HMS3260L05 |
BCP21681 |
ZINC1081243 |
5-BROMO-2-DEOXY URIDINE |
Tox21_111016 |
Tox21_200106 |
Tox21_500212 |
BDBM50207303 |
BrdU (5-Bromo-2?? -deoxyuridine) |
HG1160 |
SBB002964 |
STL530083 |
AKOS001715166 |
AKOS016015753 |
AKOS037495737 |
Tox21_111016_1 |
CCG-204307 |
DB12028 |
LP00212 |
MCULE-5086148258 |
SDCCGSBI-0050200.P002 |
uridine, 3-15N-5-bromo-2-deoxy- |
5-Bromo-1-(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-ylpyrimidine-2,4-dione |
NCGC00090770-01 |
NCGC00090770-02 |
NCGC00090770-03 |
NCGC00090770-04 |
NCGC00090770-06 |
NCGC00090770-07 |
NCGC00090770-08 |
NCGC00090770-09 |
NCGC00090770-14 |
NCGC00175901-01 |
NCGC00257660-01 |
NCGC00260897-01 |
AS-11762 |
HY-15910 |
ST057095 |
AB0010697 |
5-Bromo-2-deoxyuridine, >=99% (HPLC) |
EU-0100212 |
5-Bromo-2-deoxyuridine, BioUltra, >=99%" |
5-Bromo-2-deoxyuridine, >=99.0% (HPLC) |
B 5002 |
D01763 |
5- Br-2 inverted exclamation mark -deoxyuridine |
006B529 |
140455-EP2277565A2 |
140455-EP2277566A2 |
140455-EP2277567A1 |
140455-EP2277568A2 |
140455-EP2277569A2 |
140455-EP2277570A2 |
140455-EP2292280A1 |
156905-EP2284178A2 |
156905-EP2284179A2 |
Q419861 |
SR-01000075718 |
J-700086 |
SR-01000075718-1 |
Br-dU; 5-Bromo-1-(2-deoxy-beta-D-ribofuranosyl)uracil |
Carbobenzoxy-valyl-alanyl-aspartyl-O-methyl-fluoromethylketone |
(+)-5-bromo-1-(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl- pyrimidine-2,4-dione |
5-bromo-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-4-hydroxypyrimidin-2(1H)-one |
396726-49-1 |
5-bromo-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyridine-2,4(1H,3H)-dione |
5-bromo-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione |
Experimental Data
5-BROMO-2'-DEOXYURIDINE
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | 0 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
5-BROMO-2'-DEOXYURIDINE
Statistics Data
5-BROMO-2'-DEOXYURIDINE
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 0 | 1 | 1 |
Statistics Data Visualization
5-BROMO-2'-DEOXYURIDINE
